GEROVIT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GEROVIT
Largest movements
- Receivables within one year +€26,440
up €26,440 (+61.7%), from €42,845 to €69,285
of which Trade receivables: +€31,460
- Cash -€20,160
down €20,160 (-75.1%), from €26,857 to €6,697
mainly Receivables within one year (-€26,440) and Net result for the year (-€96)
- Stocks and contracts -€1,500
down €1,500 (-55.6%), from €2,700 to €1,200
- Trade debts +€4,792
up €4,792 (+46.2%), from €10,374 to €15,166
- Gross operating margin -€8,533
down €8,533 (-92.4%), from €9,235 to €702
- Other operating charges -€528
down €528 (-40.4%), from €1,307 to €779
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €72,402 | €77,182 | +€4,780 | +6.6% |
| Current assets | 29/58 | €72,402 | €77,182 | +€4,780 | +6.6% |
| Stocks and contracts in progress | 3 | €2,700 | €1,200 | -€1,500 | -55.6% |
| Stocks | 30/36 | €2,700 | €1,200 | -€1,500 | -55.6% |
| Amounts receivable within one year | 40/41 | €42,845 | €69,285 | +€26,440 | +61.7% |
| Trade receivables | 40 | €31,514 | €62,974 | +€31,460 | +99.8% |
| Other amounts receivable | 41 | €11,330 | €6,311 | -€5,020 | -44.3% |
| Cash at bank and in hand | 54/58 | €26,857 | €6,697 | -€20,160 | -75.1% |
| Total equity and liabilities | 10/49 | €72,402 | €77,182 | +€4,780 | +6.6% |
| Equity | 10/15 | €56,966 | €56,870 | -€96 | -0.2% |
| Contributions | 10/11 | €61,973 | €61,973 | = | 0.0% |
| Capital | 10 | €61,973 | €61,973 | = | 0.0% |
| Issued capital | 100 | €61,973 | €61,973 | = | 0.0% |
| Reserves | 13 | €17,187 | €17,187 | = | 0.0% |
| Non-distributable reserves | 130/1 | €2,561 | €2,561 | = | 0.0% |
| Legal reserve | 130 | €2,561 | €2,561 | = | 0.0% |
| Distributable reserves | 133 | €14,626 | €14,626 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€22,195 | -€22,291 | -€96 | -0.4% |
| Amounts payable | 17/49 | €15,436 | €20,312 | +€4,876 | +31.6% |
| Amounts payable within one year | 42/48 | €15,436 | €20,312 | +€4,876 | +31.6% |
| Trade debts | 44 | €10,374 | €15,166 | +€4,792 | +46.2% |
| Suppliers | 440/4 | €10,374 | €15,166 | +€4,792 | +46.2% |
| Taxes, remuneration and social security | 45 | €62 | €81 | +€19 | +31.3% |
| Taxes | 450/3 | €62 | €81 | +€19 | +31.3% |
| Other amounts payable | 47/48 | €5,000 | €5,064 | +€64 | +1.3% |
| Other operating charges | 640/8 | €1,307 | €779 | -€528 | -40.4% |
| Gross operating margin | 9900 | €9,235 | €702 | -€8,533 | -92.4% |
| Operating profit (loss) | 9901 | €7,929 | -€77 | -€8,005 | |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €18 | €19 | +€1 | +7.4% |
| Recurring financial charges | 65 | €18 | €19 | +€1 | +7.4% |
| Profit (loss) for the period before taxes | 9903 | €7,911 | -€96 | -€8,007 | |
| Profit (loss) for the period | 9904 | €7,911 | -€96 | -€8,007 | |
| Profit (loss) for the period to be appropriated | 9905 | €7,911 | -€96 | -€8,007 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.